Prolonged Aβ treatment leads to impairment in the ability of primary cortical neurons to maintain K+ and Ca2+ homeostasis
详细信息 查看全文
- 作者：Lana Shabala (1)
Claire Howells (1)
Adrian K West (1)
Roger S Chung (1) - 刊名：Molecular Neurodegeneration
- 出版年：2010
- 出版时间：December 2010
- 年：2010
- 卷：5
- 期：1
- 全文大小：878KB
- 参考文献：1. Blennow K, de Leon MJ, Zetterberg H: Alzheimer's disease. / Lancet 2006, 368:387-03. CrossRef
2. Selkoe DJ, Podlisny MB: Deciphering the genetic basis of Alzheimer's disease. / Annu Rev Genomics Hum Genet 2002, 3:67-9. CrossRef
3. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G: Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. / Science 1996, 274:99-02. CrossRef
4. Koistinaho M, Ort M, Cimadevilla JM, Vondrous R, Cordell B, Koistinaho J, Bures J, Higgins LS: Specific spatial learning deficits become severe with age in beta -amyloid precursor protein transgenic mice that harbor diffuse beta -amyloid deposits but do not form plaques. / Proc Natl Acad Sci USA 2001, 98:14675-4680. CrossRef
5. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL: Diffusible, nonfibrillar ligands derived from Abeta1-2 are potent central nervous system neurotoxins. / Proc Natl Acad Sci USA 1998, 95:6448-453. CrossRef
6. Deshpande A, Mina E, Glabe C, Busciglio J: Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. / J Neurosci 2006, 26:6011-018. CrossRef
7. Supnet C, Bezprozvanny I: The dysregulation of intracellular calcium in Alzheimer disease. / Cell Calcium 2010, 47:183-89. CrossRef
8. Parameshwaran K, Dhanasekaran M, Suppiramaniam V: Amyloid beta peptides and glutamatergic synaptic dysregulation. / Exp Neurol 2008, 210:7-3. CrossRef
9. Choi DW: Glutamate neurotoxicity and diseases of the nervous system. / Neuron 1988, 1:623-34. CrossRef
10. Smythies J: The neurotoxicity of glutamate, dopamine, iron and reactive oxygen species: functional interrelationships in health and disease: a review-discussion. / Neurotox Res 1999, 1:27-9. CrossRef
11. Sattler R, Tymianski M: Molecular mechanisms of calcium dependent excitotoxicity. / J Mol Med 2000, 78:3-3. CrossRef
12. Yu JT, Chang RC, Tan L: Calcium dysregulation in Alzheimer's disease: from mechanisms to therapeutic opportunities. / Prog Neurobiol 2009, 89:240-55. CrossRef
13. Conley YP, Mukherjee A, Kammerer C, DeKosky ST, Kamboh MI, Finegold DN, Ferrell RE: Evidence supporting a role for the calcium-sensing receptor in Alzheimer disease. / Neuron 2008, 59:190-94. CrossRef
14. Bojarski L, Herms J, Kuznicki J: Calcium dysregulation in Alzheimer's disease. / Neurochem Int 2008, 52:621-33. CrossRef
15. Kerrigan TL, Atkinson L, Peers C, Pearson HA: Modulation of 'A'-type K + current by rodent and human forms of amyloid beta protein. / Neuroreport 2008, 19:839-43. CrossRef
16. Mulholland PJ, Carpenter-Hyland EP, Hearing MC, Becker HC, Woodward JJ, Chandler LJ: Glutamate transporters regulate extrasynaptic NMDA receptor modulation of Kv2.1 potassium channels. / J Neurosci 2008, 28:8801-809. CrossRef
17. Shabala L, Ross T, Newman I, McMeekin T, Shabala S: Measurements of net fluxes and extracellular changes of H + , Ca 2+ , K + , and NH 4 + in Escherichia coli using ion-selective microelectrodes. / J Microbiol Meth 2001, 46:119-29. CrossRef
18. Shabala L, Ross T, McMeekin T, Shabala S: Non-invasive microelectrode ion flux measurements to study adaptive responses of microorganisms to the environment. / FEMS Microbiol Rev 2006, 30:472-86. CrossRef
19. Chin JH, Tse FW, Harris K, Jhamandas JH: Beta-amyloid enhances intracellular calcium rises mediated by repeated activation of intracellular calcium stores and nicotinic receptors in acutely dissociated rat basal forebrain neurons. / Brain Cell Biol 2006, 35:173-6. CrossRef
20. Pannaccione A, Secondo A, Scorziello A, Calì G, Taglialatela M, Annunziato L: Nuclear factor-kappaB activation by reactive oxygen species mediates voltage-gated K + current enhancement by neurotoxic beta-amyloid peptides in nerve growth factor-differentiated PC-12 cells and hippocampal neurones. / J Neurochem 2005, 94:572-86. CrossRef
21. Pannaccione A, Boscia F, Scorziello A, Adornetto A, Castaldo P, Sirabella R, Taglialatela M, Di Renzo GF, Annunziato L: Up-regulation and increased activity of KV3.4 channels and their accessory subunit MinK-related peptide 2 induced by amyloid peptide are involved in apoptotic neuronal death. / Mol Pharmacol 2007, 72:499-01. CrossRef
22. Choi E, Abbott GW: The MiRP2-Kv3.4 potassium channel: muscling in on Alzheimer's disease. / Mol Pharmacol 2007, 72:499-01. CrossRef
23. Angulo E, Noé V, Casadó V, Mallol J, Gomez-Isla T, Lluis C, Ferrer I, Ciudad CJ, Franco R: Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease. / J Neurochem 2004, 91:547-57. CrossRef
24. Mark RJ, Hensley K, Butterfield DA, Mattson MP: Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca 2+ homeostasis and cell death. / J Neurosci 1995, 15:6239-249.
25. Dickey CA, Gordon MN, Wilcock DM, Herber DL, Freeman MJ, Morgan D: Dysregulation of Na + /K + -ATPase by amyloid in APP+PS1 transgenic mice. / BMC Neurosci 2005, 6:7. CrossRef
26. Xiao AY, Homma M, Wang XQ, Wang X, Yu SP: Role of K + efflux in apoptosis induced by AMPA and kainate in mouse cortical neurons. / Neurosci 2001, 108:61-7. CrossRef
27. Zhao YM, Sun LN, Zhou HY, Wang XL: Voltage-dependent potassium channels are involved in glutamate-induced apoptosis of rat hippocampal neurons. / Neurosci Lett 2006, 398:22-7. CrossRef
28. White AR, Guirguis R, Brazier MW, Jobling MF, Hill AF, Beyreuther K, Barrow CJ, Masters CL, Collins SJ, Cappai R: Sublethal concentrations of prion peptide PrP106-26 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons. / Neurobiol Dis 2001, 8:299-16. CrossRef
29. Perrella J, Bhavnani BR: Protection of cortical cells by equine estrogens against glutamate-induced excitotoxicity is mediated through a calcium independent mechanism. / BMC Neurosci 2005, 6:34. CrossRef
30. Lei Z, Deng P, Xu ZC: Regulation of Kv4.2 channels by glutamate in cultured hippocampal neurons. / J Neurochem 2008, 106:182-92. CrossRef
31. Frick A, Magee J, Johnston D: LTP is accompanied by an enhanced local excitability of pyramidal neuron dendrites. / Nat Neurosci 2004, 7:126-35. CrossRef
32. Lisman J, Spruston N: Postsynaptic depolarization requirements for LTP and LTD: a critique of spike timing-dependent plasticity. / Nat Neurosci 2005, 8:839-41.
33. Magee JC, Johnston D: A synaptically controlled, associative signal for Hebbian plasticity in hippocampal neurons. / Science 1997, 275:209-13. CrossRef
34. White MJ, DiCaprio MJ, Greenberg DA: Assessment of neuronal viability with Alamar Blue in cortical and granule cell cultures. / J Neurosci Methods 1996, 70:195-00. CrossRef
35. Chung RS, McCormack GH, King AE, West AK, Vickers JC: Glutamate induces rapid loss of axonal neurofilament proteins from cortical neurons in vitro. / Exp Neurol 2005,193(2):481-. CrossRef - 作者单位：Lana Shabala (1)
Claire Howells (1)
Adrian K West (1)
Roger S Chung (1)
1. NeuroRepair Group, Menzies Research Institute, University of Tasmania, Private Bag 23, Hobart, Tasmania, 7001, Australia
文摘
Background Alzheimer's disease (AD) is a progressive neurodegenerative disease, characterised by the formation of insoluble amyloidogenic plaques and neurofibrillary tangles. Beta amyloid (Aβ) peptide is one of the main constituents in Aβ plaques, and is thought to be a primary causative agent in AD. Neurons are likely to be exposed to chronic, sublethal doses of Aβ over an extended time during the pathogenesis of AD, however most studies published to date using in vitro models have focussed on acute studies. To experimentally model the progressive pathogenesis of AD, we exposed primary cortical neurons daily to 1 μM of Aβ1-40 over 7 days and compared their survival with age-similar untreated cells. We also investigated whether chronic Aβ exposure affects neuronal susceptibility to the subsequent acute excitotoxicity induced by 10 μM glutamate and assessed how Ca2+ and K+ homeostasis were affected by either treatment. Results We show that continuous exposure to 1 μM Aβ1-40 for seven days decreased survival of cultured cortical neurons by 20%. This decrease in survival correlated with increased K+ efflux from the cells. One day treatment with 1 μM Aβ followed by glutamate led to a substantially higher K+ efflux than in the age-similar untreated control. This difference further increased with the duration of the treatment. K+ efflux also remained higher in Aβ treated cells 20 min after glutamate application leading to 2.8-fold higher total K+ effluxed from the cells compared to controls. Ca2+ uptake was significantly higher only after prolonged Aβ treatment with 2.5-fold increase in total Ca2+ uptake over 20 min post glutamate application after six days of Aβ treatment or longer (P < 0.05). Conclusions Our data suggest that long term exposure to Aβ is detrimental because it reduces the ability of cortical neurons to maintain K+ and Ca2+ homeostasis in response to glutamate challenge, a response that might underlie the early symptoms of AD. The observed inability to maintain K+ homeostasis might furthermore be useful in future studies as an early indicator of pathological changes in response to Aβ.